Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × ralimetinib × Clear all

Phase

Status

Completed 3 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 347 Carboplatin 293 pembrolizumab 276 Gemcitabine 276 Cisplatin 275 Radiotherapy 263 Paclitaxel 257 Docetaxel 251 Bevacizumab 217 Rituximab 204 Capecitabine 196 Nivolumab 186 Dexamethasone 176 Fluorouracil 172 fludarabine 159 Oxaliplatin 151 Doxorubicin 138 Leucovorin 128 Irinotecan 128 Pemetrexed 125 Etoposide 125 Cytarabine 122 fludarabine phosphate 113 Bortezomib 112 Lenalidomide 109 Filgrastim 108 Cetuximab 107 Erlotinib Hydrochloride 103 Temozolomide 99 Radiation 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02322853 2017-05-24

OLYMPE

Centre Francois Baclesse

Phase 2 Terminated

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡